Posted 1 day ago

Pfizer (PFE) was, at one time, the most owned stock in the world and the darling of individual and institutional investors alike. Despite looming patent expirations, an anemic pipeline and a stock tha

Posted 1 day ago

The dreaded FDA complete response letter, so often seen as a major setback and perceived negatively by investors in afflicted companies, was Monday welcomed with open arms by shareholders in Amylin

Posted 1 day ago

By Jon Najarian Loss Is Worse Than Expected

Posted 1 day ago

Anyone who doesn't own Boston Scientific (BSX) is once again breathing a sigh of relief. It seems like an ever shrinking list. Holders of BSX include Paulson & Co., Primecap, Dodge & Cox, Welling

Tags: health

Posted 1 day ago

Boston Scientific (BSX) announced Monday that it's halting sales of its implantable cardioverter defibrillators (ICDs). The suspension was due to filing errors and not safety issues, but the company

Posted 1 day ago

Vanda Pharmaceuticals (VNDA):Shares of Vanda Pharmaceuticals have been on the move of late after Hapoalim Securities initiated coverage of the company with a 'BUY' rating and issued a price target o

Tags: biotech

Posted 1 day ago

One of the companies we've been following most closely, Neostem, Inc. (AMEX: NBS), is presenting at the Roth Capital Partners 22nd Annual OC Growth Stock Conference in Southern California today. Las

Posted 1 day ago

Sequenom Inc. (SQNM)Q4 2009 Earnings CallMarch 15, 2010 4:30 pm ET

Posted 1 day ago

Now that Arena Pharmaceuticals (ARNA), Vivus (VVUS) and Orexigen Therapeutics (OREX) have all announced full year 2009 financial results, it's time to revisit my pet strategy of investing in the obe

Posted 2 days ago

Amgen Inc. (AMGN - $56.90) is the world s largest independent biotechnology medicines company. They discover, develop, manufacture and market medicines for serious illnesses. Their focus is on human

Tags: biotech biotechnology